In Depth 18 Dec 2024 AI + CRISPR: The explosive fusion that will redefine biotechnology With AI taking more and more space in biotech, CRISPR stands out as one of the most promising avenues for AI integration. December 18, 2024 - 6 minutesmins - By Jules Adam Share WhatsApp Twitter Linkedin Email
In Depth 17 Dec 2024 Ovarian cancer: BioNTech, Curelab, OvarianVax and more bring vaccines to the clinic A number of ovarian cancer vaccines are being evaluated including the world’s first cancer prevention vaccine, which recently received funding. December 17, 2024 - 9 minutesmins - By Roohi Mariam Peter Share WhatsApp Twitter Linkedin Email
Best in Biotech 16 Dec 2024 10 biotech companies to watch in 2025 As 2025 is expected to be an exciting year for the biopharma industry, discover ten biotech companies to keep an eye on in 2025. December 16, 2024 - 14 minutesmins - By Willow Shah-Neville Share WhatsApp Twitter Linkedin Email
In Depth 13 Dec 2024 Is China the future of biotech? Delve into the ongoing transformation of China’s biotech industry in the last 10 years and in the future evolving geopolitical context. December 13, 2024 - 12 minutesmins - By Jules Adam Share WhatsApp Twitter Linkedin Email
Podcast 13 Dec 2024Finding new treatments for peanut allergy Individuals with peanut allergies are at constant risk of severe reactions, and this week, we talk about new treatments with Jessica Grossman of IgGenix. December 13, 2024 Share WhatsApp Twitter Linkedin Email Listen Now Apple Music Spotify More
News and Trends 12 Dec 2024 Top biotech deals of November 2024 November has seen a variety of biotech deals take place to advance therapies across different stages in development. December 12, 2024 - 9 minutesmins - By Roohi Mariam Peter Share WhatsApp Twitter Linkedin Email
In Depth 11 Dec 2024 Targeting sugar molecules: Can glycobiology lead to a new era for cancer immunotherapy? Find out more about the emerging field of glycobiology, which could potentially lead to a new type of cancer immunotherapy. December 11, 2024 - 9 minutesmins - By Willow Shah-Neville Share WhatsApp Twitter Linkedin Email
Reports Produced by Inpart 11 Dec 2024Antibody Therapy R&D trends and breakthrough innovations Check out a new report exploring R&D trends and breakthrough innovations leveraging antibodies to create potentially game-changing therapies, published by our parent company Inpart. December 11, 2024 Share WhatsApp Twitter Linkedin Email Produced by Inpart
More News! 10 Dec 2024 Biotech in 2024: A retrospective 2024 is coming to a close and it is time to look at how biotech performed this year. Was it a triumph or a year of cautious optimism? December 10, 2024 - 14 minutesmins - By Jules Adam Share WhatsApp Twitter Linkedin Email
In Depth 9 Dec 2024 CAR-T cell therapy for lupus: An emerging field with great potential Discover how the emerging field of using CAR-T cell therapy to treat lupus could offer a potential cure for the autoimmune disorder. December 9, 2024 - 10 minutesmins - By Willow Shah-Neville Share WhatsApp Twitter Linkedin Email
Podcast 6 Dec 2024Cracking the code of biotech valuations Our guest on the podcast this week to discuss the biotech scene in Eastern Europe, and look at some of the challenges facing biotech companies is Adam Marťák, CEO of ambiom. December 6, 2024 Share WhatsApp Twitter Linkedin Email Listen Now Apple Music Spotify More
In Depth 5 Dec 2024 The biggest private biotech investments in November 2024 The companies Metsera, Alentis Therapeutics, and Adcendo bagged the biggest private biotech investments in November 2024. December 5, 2024 - 3 minutesmins - By Willow Shah-Neville Share WhatsApp Twitter Linkedin Email